Form 4 for PVLA PALVELLA THERAPEUTICS, INC.
Accepted 2022-05-16 00:00:00 ET · period of report 2022-05-13 · accession 0001583648-22-000030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-16 | 2022-05-13 | PVLA | Demuth Tim | Chief Medical Off | P - Purchase | $1.71 | +6,000 | 6,000 | New | +$10.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-13 | P | A | 6,000 | $1.71 | 6,000 | D | — | — | (F1) Purchase price was 1.65 Euros per share which was converted into dollars using the noon buying rate of 1.00 Euro to $1.03745 based on information provided on May 13, 2022 via Xignite. |